| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,925 |
1,638 |
$80K |
| 99215 |
Prolong outpt/office vis |
656 |
207 |
$60K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,219 |
989 |
$27K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
671 |
553 |
$25K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
504 |
492 |
$24K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
445 |
404 |
$18K |
| 99417 |
Prolong home eval add 15m |
132 |
38 |
$12K |
| 80305 |
|
1,170 |
992 |
$9K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
130 |
115 |
$9K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
528 |
396 |
$4K |
| M0244 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency |
41 |
15 |
$3K |
| 87428 |
|
39 |
37 |
$2K |
| 99201 |
|
44 |
44 |
$1K |
| 81025 |
|
318 |
254 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
55 |
53 |
$919.17 |
| 96127 |
|
276 |
174 |
$573.54 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
116 |
104 |
$333.52 |
| 36415 |
Collection of venous blood by venipuncture |
92 |
85 |
$135.05 |
| 86580 |
|
20 |
13 |
$29.47 |